High-strength nicotine pouch extracts caused acute oxidative stress, DNA-damage signals and mitochondrial injury in primary human oral keratinocytes, with the 30 mg product showing greater cytotoxic potency than the 20 mg version, researchers reported November 3 in Frontiers in Medicine.
The study, led by Helal G. Alanazi and Fatema F. Elturki with Ghada A. Gehani among 11 authors across four universities — Prince Sattam bin Abdulaziz University in Saudi Arabia, and the University of Benghazi and University of Sirte in Libya — exposed primary human oral keratinocytes for 24 hours to aqueous extracts from commercial pouches labeled 20 mg and 30 mg nicotine per pouch.
The 30 mg extract reached a half-maximal inhibitory concentration (IC₅₀) at 49.6% of stock strength, versus 83.2% for the 20 mg extract, indicating higher potency.
At their respective IC₅₀ levels, both extracts reduced the antioxidant enzymes catalase (CAT) and superoxide dismutase (SOD), while increasing malondialdehyde (MDA) and nitric oxide (NO) — markers of lipid peroxidation and oxidative stress. TP53 mRNA rose 2.31-fold and 3.16-fold above control for the 20 mg and 30 mg extracts, respectively, while EGFR mRNA fell to 0.62-fold and 0.47-fold.

Transmission electron microscopy revealed mitochondrial swelling, cristae disruption, chromatin condensation, cytoplasmic vacuolization and plasma membrane injury, with more extensive changes after the 30 mg exposure. Cell-death populations quantified by Annexin V-FITC/propidium iodide flow cytometry showed predominantly necrotic death, and the viable cell fraction decreased for both extracts.
Primary human oral keratinocytes (HOKs) form the frontline barrier of the oral mucosa. The researchers chose them because they maintain epithelial homeostasis, regulate tissue repair and are the first cells exposed when a pouch sits against the gum.
“The effects are not limited to cell viability; they can also alter the cells' normal functions,” said Sanna Palosaari, adjunct professor at the University of Oulu, commenting on a study of mesenchymal stromal cells published in Archives of Toxicology.
A University of Oulu study published in Archives of Toxicology found that nicotine and cigarette smoke extract trigger acute cell-death and lysosomal stress responses in human mesenchymal stromal cells. Both studies show that local oral concentrations from pouches can far exceed systemic levels.
The Frontiers in Medicine authors cautioned that their extracts contained the full formulation — flavorings, humectants, pH adjusters and other constituents — not just nicotine. “It is not appropriate to refer to these results as a controlled nicotine dose-response due to the fact that whole-product extracts were used instead of isolated nicotine,” they wrote. The 30 mg product’s greater toxicity may reflect differences in total chemical composition beyond the labeled nicotine content.
Prince Sattam bin Abdulaziz University, located in Al-Kharj, Saudi Arabia, was established by royal decree in 2007 as the independent University of Al-Kharj after separating from a King Saud University branch. The university operates multiple campuses, including sites in Wadi Addawasir, Hotat Bani Tamim, Aflaj, and Slayel, and hosts a College of Dentistry with departments in oral and maxillofacial surgery and preventive dental sciences.
The findings add to a small but growing body of in vitro evidence that high-strength pouch formulations can disrupt oral epithelial biology at the site of contact.